Medical Care
Global LNP-mRNA Therapy Market Research Report 2025
- Mar 27, 25
- ID: 162069
- Pages: 78
- Figures: 76
- Views: 14
The global market for LNP-mRNA Therapy was valued at US$ 547 million in the year 2024 and is projected to reach a revised size of US$ 767 million by 2031, growing at a CAGR of 5.6% during the forecast period.
LNP-mRNA Therapy represents a cutting-edge biomedical technology that leverages the unique strengths of Lipid Nanoparticles (LNPs) and Messenger RNA (mRNA) to offer novel treatment avenues for various diseases. Serving as carriers, LNPs effectively shield mRNA from enzymatic degradation in the body and deliver it precisely to target cells. mRNA carries the genetic information necessary for synthesizing specific proteins; once inside cells, it directs the cells to produce these proteins, thereby triggering immune responses or repairing damaged tissues. This therapy demonstrates significant potential in treating cancers, genetic disorders, and infectious diseases. Its highly personalized and rapid-response characteristics have made LNP-mRNA Therapy a research focus in the biomedical field. By precisely regulating gene expression, LNP-mRNA Therapy provides patients with unprecedented treatment options, ushering in a new era of precision medicine.
North American market for LNP-mRNA Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for LNP-mRNA Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for LNP-mRNA Therapy in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of LNP-mRNA Therapy include Genevant Sciences, Moderna, BioNTech, Pfizer, NanoVation Therapeutics, CureVac, Sanofi, Promab, Grand Pharm, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for LNP-mRNA Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding LNP-mRNA Therapy.
The LNP-mRNA Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global LNP-mRNA Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the LNP-mRNA Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Genevant Sciences
Moderna
BioNTech
Pfizer
NanoVation Therapeutics
CureVac
Sanofi
Promab
Grand Pharm
Segment by Type
Passive Targeting
Active Targeting
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of LNP-mRNA Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
LNP-mRNA Therapy represents a cutting-edge biomedical technology that leverages the unique strengths of Lipid Nanoparticles (LNPs) and Messenger RNA (mRNA) to offer novel treatment avenues for various diseases. Serving as carriers, LNPs effectively shield mRNA from enzymatic degradation in the body and deliver it precisely to target cells. mRNA carries the genetic information necessary for synthesizing specific proteins; once inside cells, it directs the cells to produce these proteins, thereby triggering immune responses or repairing damaged tissues. This therapy demonstrates significant potential in treating cancers, genetic disorders, and infectious diseases. Its highly personalized and rapid-response characteristics have made LNP-mRNA Therapy a research focus in the biomedical field. By precisely regulating gene expression, LNP-mRNA Therapy provides patients with unprecedented treatment options, ushering in a new era of precision medicine.
North American market for LNP-mRNA Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for LNP-mRNA Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for LNP-mRNA Therapy in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of LNP-mRNA Therapy include Genevant Sciences, Moderna, BioNTech, Pfizer, NanoVation Therapeutics, CureVac, Sanofi, Promab, Grand Pharm, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for LNP-mRNA Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding LNP-mRNA Therapy.
The LNP-mRNA Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global LNP-mRNA Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the LNP-mRNA Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Genevant Sciences
Moderna
BioNTech
Pfizer
NanoVation Therapeutics
CureVac
Sanofi
Promab
Grand Pharm
Segment by Type
Passive Targeting
Active Targeting
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of LNP-mRNA Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global LNP-mRNA Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Passive Targeting
1.2.3 Active Targeting
1.3 Market by Application
1.3.1 Global LNP-mRNA Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global LNP-mRNA Therapy Market Perspective (2020-2031)
2.2 Global LNP-mRNA Therapy Growth Trends by Region
2.2.1 Global LNP-mRNA Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 LNP-mRNA Therapy Historic Market Size by Region (2020-2025)
2.2.3 LNP-mRNA Therapy Forecasted Market Size by Region (2026-2031)
2.3 LNP-mRNA Therapy Market Dynamics
2.3.1 LNP-mRNA Therapy Industry Trends
2.3.2 LNP-mRNA Therapy Market Drivers
2.3.3 LNP-mRNA Therapy Market Challenges
2.3.4 LNP-mRNA Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top LNP-mRNA Therapy Players by Revenue
3.1.1 Global Top LNP-mRNA Therapy Players by Revenue (2020-2025)
3.1.2 Global LNP-mRNA Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Top LNP-mRNA Therapy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by LNP-mRNA Therapy Revenue
3.4 Global LNP-mRNA Therapy Market Concentration Ratio
3.4.1 Global LNP-mRNA Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by LNP-mRNA Therapy Revenue in 2024
3.5 Global Key Players of LNP-mRNA Therapy Head office and Area Served
3.6 Global Key Players of LNP-mRNA Therapy, Product and Application
3.7 Global Key Players of LNP-mRNA Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 LNP-mRNA Therapy Breakdown Data by Type
4.1 Global LNP-mRNA Therapy Historic Market Size by Type (2020-2025)
4.2 Global LNP-mRNA Therapy Forecasted Market Size by Type (2026-2031)
5 LNP-mRNA Therapy Breakdown Data by Application
5.1 Global LNP-mRNA Therapy Historic Market Size by Application (2020-2025)
5.2 Global LNP-mRNA Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America LNP-mRNA Therapy Market Size (2020-2031)
6.2 North America LNP-mRNA Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America LNP-mRNA Therapy Market Size by Country (2020-2025)
6.4 North America LNP-mRNA Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe LNP-mRNA Therapy Market Size (2020-2031)
7.2 Europe LNP-mRNA Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe LNP-mRNA Therapy Market Size by Country (2020-2025)
7.4 Europe LNP-mRNA Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific LNP-mRNA Therapy Market Size (2020-2031)
8.2 Asia-Pacific LNP-mRNA Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific LNP-mRNA Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific LNP-mRNA Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America LNP-mRNA Therapy Market Size (2020-2031)
9.2 Latin America LNP-mRNA Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America LNP-mRNA Therapy Market Size by Country (2020-2025)
9.4 Latin America LNP-mRNA Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa LNP-mRNA Therapy Market Size (2020-2031)
10.2 Middle East & Africa LNP-mRNA Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa LNP-mRNA Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa LNP-mRNA Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Genevant Sciences
11.1.1 Genevant Sciences Company Details
11.1.2 Genevant Sciences Business Overview
11.1.3 Genevant Sciences LNP-mRNA Therapy Introduction
11.1.4 Genevant Sciences Revenue in LNP-mRNA Therapy Business (2020-2025)
11.1.5 Genevant Sciences Recent Development
11.2 Moderna
11.2.1 Moderna Company Details
11.2.2 Moderna Business Overview
11.2.3 Moderna LNP-mRNA Therapy Introduction
11.2.4 Moderna Revenue in LNP-mRNA Therapy Business (2020-2025)
11.2.5 Moderna Recent Development
11.3 BioNTech
11.3.1 BioNTech Company Details
11.3.2 BioNTech Business Overview
11.3.3 BioNTech LNP-mRNA Therapy Introduction
11.3.4 BioNTech Revenue in LNP-mRNA Therapy Business (2020-2025)
11.3.5 BioNTech Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer LNP-mRNA Therapy Introduction
11.4.4 Pfizer Revenue in LNP-mRNA Therapy Business (2020-2025)
11.4.5 Pfizer Recent Development
11.5 NanoVation Therapeutics
11.5.1 NanoVation Therapeutics Company Details
11.5.2 NanoVation Therapeutics Business Overview
11.5.3 NanoVation Therapeutics LNP-mRNA Therapy Introduction
11.5.4 NanoVation Therapeutics Revenue in LNP-mRNA Therapy Business (2020-2025)
11.5.5 NanoVation Therapeutics Recent Development
11.6 CureVac
11.6.1 CureVac Company Details
11.6.2 CureVac Business Overview
11.6.3 CureVac LNP-mRNA Therapy Introduction
11.6.4 CureVac Revenue in LNP-mRNA Therapy Business (2020-2025)
11.6.5 CureVac Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi LNP-mRNA Therapy Introduction
11.7.4 Sanofi Revenue in LNP-mRNA Therapy Business (2020-2025)
11.7.5 Sanofi Recent Development
11.8 Promab
11.8.1 Promab Company Details
11.8.2 Promab Business Overview
11.8.3 Promab LNP-mRNA Therapy Introduction
11.8.4 Promab Revenue in LNP-mRNA Therapy Business (2020-2025)
11.8.5 Promab Recent Development
11.9 Grand Pharm
11.9.1 Grand Pharm Company Details
11.9.2 Grand Pharm Business Overview
11.9.3 Grand Pharm LNP-mRNA Therapy Introduction
11.9.4 Grand Pharm Revenue in LNP-mRNA Therapy Business (2020-2025)
11.9.5 Grand Pharm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global LNP-mRNA Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Passive Targeting
1.2.3 Active Targeting
1.3 Market by Application
1.3.1 Global LNP-mRNA Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global LNP-mRNA Therapy Market Perspective (2020-2031)
2.2 Global LNP-mRNA Therapy Growth Trends by Region
2.2.1 Global LNP-mRNA Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 LNP-mRNA Therapy Historic Market Size by Region (2020-2025)
2.2.3 LNP-mRNA Therapy Forecasted Market Size by Region (2026-2031)
2.3 LNP-mRNA Therapy Market Dynamics
2.3.1 LNP-mRNA Therapy Industry Trends
2.3.2 LNP-mRNA Therapy Market Drivers
2.3.3 LNP-mRNA Therapy Market Challenges
2.3.4 LNP-mRNA Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top LNP-mRNA Therapy Players by Revenue
3.1.1 Global Top LNP-mRNA Therapy Players by Revenue (2020-2025)
3.1.2 Global LNP-mRNA Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Top LNP-mRNA Therapy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by LNP-mRNA Therapy Revenue
3.4 Global LNP-mRNA Therapy Market Concentration Ratio
3.4.1 Global LNP-mRNA Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by LNP-mRNA Therapy Revenue in 2024
3.5 Global Key Players of LNP-mRNA Therapy Head office and Area Served
3.6 Global Key Players of LNP-mRNA Therapy, Product and Application
3.7 Global Key Players of LNP-mRNA Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 LNP-mRNA Therapy Breakdown Data by Type
4.1 Global LNP-mRNA Therapy Historic Market Size by Type (2020-2025)
4.2 Global LNP-mRNA Therapy Forecasted Market Size by Type (2026-2031)
5 LNP-mRNA Therapy Breakdown Data by Application
5.1 Global LNP-mRNA Therapy Historic Market Size by Application (2020-2025)
5.2 Global LNP-mRNA Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America LNP-mRNA Therapy Market Size (2020-2031)
6.2 North America LNP-mRNA Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America LNP-mRNA Therapy Market Size by Country (2020-2025)
6.4 North America LNP-mRNA Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe LNP-mRNA Therapy Market Size (2020-2031)
7.2 Europe LNP-mRNA Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe LNP-mRNA Therapy Market Size by Country (2020-2025)
7.4 Europe LNP-mRNA Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific LNP-mRNA Therapy Market Size (2020-2031)
8.2 Asia-Pacific LNP-mRNA Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific LNP-mRNA Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific LNP-mRNA Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America LNP-mRNA Therapy Market Size (2020-2031)
9.2 Latin America LNP-mRNA Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America LNP-mRNA Therapy Market Size by Country (2020-2025)
9.4 Latin America LNP-mRNA Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa LNP-mRNA Therapy Market Size (2020-2031)
10.2 Middle East & Africa LNP-mRNA Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa LNP-mRNA Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa LNP-mRNA Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Genevant Sciences
11.1.1 Genevant Sciences Company Details
11.1.2 Genevant Sciences Business Overview
11.1.3 Genevant Sciences LNP-mRNA Therapy Introduction
11.1.4 Genevant Sciences Revenue in LNP-mRNA Therapy Business (2020-2025)
11.1.5 Genevant Sciences Recent Development
11.2 Moderna
11.2.1 Moderna Company Details
11.2.2 Moderna Business Overview
11.2.3 Moderna LNP-mRNA Therapy Introduction
11.2.4 Moderna Revenue in LNP-mRNA Therapy Business (2020-2025)
11.2.5 Moderna Recent Development
11.3 BioNTech
11.3.1 BioNTech Company Details
11.3.2 BioNTech Business Overview
11.3.3 BioNTech LNP-mRNA Therapy Introduction
11.3.4 BioNTech Revenue in LNP-mRNA Therapy Business (2020-2025)
11.3.5 BioNTech Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer LNP-mRNA Therapy Introduction
11.4.4 Pfizer Revenue in LNP-mRNA Therapy Business (2020-2025)
11.4.5 Pfizer Recent Development
11.5 NanoVation Therapeutics
11.5.1 NanoVation Therapeutics Company Details
11.5.2 NanoVation Therapeutics Business Overview
11.5.3 NanoVation Therapeutics LNP-mRNA Therapy Introduction
11.5.4 NanoVation Therapeutics Revenue in LNP-mRNA Therapy Business (2020-2025)
11.5.5 NanoVation Therapeutics Recent Development
11.6 CureVac
11.6.1 CureVac Company Details
11.6.2 CureVac Business Overview
11.6.3 CureVac LNP-mRNA Therapy Introduction
11.6.4 CureVac Revenue in LNP-mRNA Therapy Business (2020-2025)
11.6.5 CureVac Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi LNP-mRNA Therapy Introduction
11.7.4 Sanofi Revenue in LNP-mRNA Therapy Business (2020-2025)
11.7.5 Sanofi Recent Development
11.8 Promab
11.8.1 Promab Company Details
11.8.2 Promab Business Overview
11.8.3 Promab LNP-mRNA Therapy Introduction
11.8.4 Promab Revenue in LNP-mRNA Therapy Business (2020-2025)
11.8.5 Promab Recent Development
11.9 Grand Pharm
11.9.1 Grand Pharm Company Details
11.9.2 Grand Pharm Business Overview
11.9.3 Grand Pharm LNP-mRNA Therapy Introduction
11.9.4 Grand Pharm Revenue in LNP-mRNA Therapy Business (2020-2025)
11.9.5 Grand Pharm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global LNP-mRNA Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Passive Targeting
Table 3. Key Players of Active Targeting
Table 4. Global LNP-mRNA Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global LNP-mRNA Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global LNP-mRNA Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global LNP-mRNA Therapy Market Share by Region (2020-2025)
Table 8. Global LNP-mRNA Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global LNP-mRNA Therapy Market Share by Region (2026-2031)
Table 10. LNP-mRNA Therapy Market Trends
Table 11. LNP-mRNA Therapy Market Drivers
Table 12. LNP-mRNA Therapy Market Challenges
Table 13. LNP-mRNA Therapy Market Restraints
Table 14. Global LNP-mRNA Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global LNP-mRNA Therapy Market Share by Players (2020-2025)
Table 16. Global Top LNP-mRNA Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LNP-mRNA Therapy as of 2024)
Table 17. Ranking of Global Top LNP-mRNA Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by LNP-mRNA Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of LNP-mRNA Therapy, Headquarters and Area Served
Table 20. Global Key Players of LNP-mRNA Therapy, Product and Application
Table 21. Global Key Players of LNP-mRNA Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global LNP-mRNA Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global LNP-mRNA Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global LNP-mRNA Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global LNP-mRNA Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global LNP-mRNA Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global LNP-mRNA Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global LNP-mRNA Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global LNP-mRNA Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America LNP-mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America LNP-mRNA Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America LNP-mRNA Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe LNP-mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe LNP-mRNA Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe LNP-mRNA Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific LNP-mRNA Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific LNP-mRNA Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific LNP-mRNA Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America LNP-mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America LNP-mRNA Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America LNP-mRNA Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa LNP-mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa LNP-mRNA Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa LNP-mRNA Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Genevant Sciences Company Details
Table 47. Genevant Sciences Business Overview
Table 48. Genevant Sciences LNP-mRNA Therapy Product
Table 49. Genevant Sciences Revenue in LNP-mRNA Therapy Business (2020-2025) & (US$ Million)
Table 50. Genevant Sciences Recent Development
Table 51. Moderna Company Details
Table 52. Moderna Business Overview
Table 53. Moderna LNP-mRNA Therapy Product
Table 54. Moderna Revenue in LNP-mRNA Therapy Business (2020-2025) & (US$ Million)
Table 55. Moderna Recent Development
Table 56. BioNTech Company Details
Table 57. BioNTech Business Overview
Table 58. BioNTech LNP-mRNA Therapy Product
Table 59. BioNTech Revenue in LNP-mRNA Therapy Business (2020-2025) & (US$ Million)
Table 60. BioNTech Recent Development
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer LNP-mRNA Therapy Product
Table 64. Pfizer Revenue in LNP-mRNA Therapy Business (2020-2025) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. NanoVation Therapeutics Company Details
Table 67. NanoVation Therapeutics Business Overview
Table 68. NanoVation Therapeutics LNP-mRNA Therapy Product
Table 69. NanoVation Therapeutics Revenue in LNP-mRNA Therapy Business (2020-2025) & (US$ Million)
Table 70. NanoVation Therapeutics Recent Development
Table 71. CureVac Company Details
Table 72. CureVac Business Overview
Table 73. CureVac LNP-mRNA Therapy Product
Table 74. CureVac Revenue in LNP-mRNA Therapy Business (2020-2025) & (US$ Million)
Table 75. CureVac Recent Development
Table 76. Sanofi Company Details
Table 77. Sanofi Business Overview
Table 78. Sanofi LNP-mRNA Therapy Product
Table 79. Sanofi Revenue in LNP-mRNA Therapy Business (2020-2025) & (US$ Million)
Table 80. Sanofi Recent Development
Table 81. Promab Company Details
Table 82. Promab Business Overview
Table 83. Promab LNP-mRNA Therapy Product
Table 84. Promab Revenue in LNP-mRNA Therapy Business (2020-2025) & (US$ Million)
Table 85. Promab Recent Development
Table 86. Grand Pharm Company Details
Table 87. Grand Pharm Business Overview
Table 88. Grand Pharm LNP-mRNA Therapy Product
Table 89. Grand Pharm Revenue in LNP-mRNA Therapy Business (2020-2025) & (US$ Million)
Table 90. Grand Pharm Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
Table 94. Authors List of This Report
List of Figures
Figure 1. LNP-mRNA Therapy Picture
Figure 2. Global LNP-mRNA Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global LNP-mRNA Therapy Market Share by Type: 2024 VS 2031
Figure 4. Passive Targeting Features
Figure 5. Active Targeting Features
Figure 6. Global LNP-mRNA Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global LNP-mRNA Therapy Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. LNP-mRNA Therapy Report Years Considered
Figure 12. Global LNP-mRNA Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global LNP-mRNA Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global LNP-mRNA Therapy Market Share by Region: 2024 VS 2031
Figure 15. Global LNP-mRNA Therapy Market Share by Players in 2024
Figure 16. Global LNP-mRNA Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by LNP-mRNA Therapy Revenue in 2024
Figure 18. North America LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America LNP-mRNA Therapy Market Share by Country (2020-2031)
Figure 20. United States LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe LNP-mRNA Therapy Market Share by Country (2020-2031)
Figure 24. Germany LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific LNP-mRNA Therapy Market Share by Region (2020-2031)
Figure 32. China LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America LNP-mRNA Therapy Market Share by Country (2020-2031)
Figure 40. Mexico LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa LNP-mRNA Therapy Market Share by Country (2020-2031)
Figure 44. Turkey LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Genevant Sciences Revenue Growth Rate in LNP-mRNA Therapy Business (2020-2025)
Figure 48. Moderna Revenue Growth Rate in LNP-mRNA Therapy Business (2020-2025)
Figure 49. BioNTech Revenue Growth Rate in LNP-mRNA Therapy Business (2020-2025)
Figure 50. Pfizer Revenue Growth Rate in LNP-mRNA Therapy Business (2020-2025)
Figure 51. NanoVation Therapeutics Revenue Growth Rate in LNP-mRNA Therapy Business (2020-2025)
Figure 52. CureVac Revenue Growth Rate in LNP-mRNA Therapy Business (2020-2025)
Figure 53. Sanofi Revenue Growth Rate in LNP-mRNA Therapy Business (2020-2025)
Figure 54. Promab Revenue Growth Rate in LNP-mRNA Therapy Business (2020-2025)
Figure 55. Grand Pharm Revenue Growth Rate in LNP-mRNA Therapy Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Table 1. Global LNP-mRNA Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Passive Targeting
Table 3. Key Players of Active Targeting
Table 4. Global LNP-mRNA Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global LNP-mRNA Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global LNP-mRNA Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global LNP-mRNA Therapy Market Share by Region (2020-2025)
Table 8. Global LNP-mRNA Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global LNP-mRNA Therapy Market Share by Region (2026-2031)
Table 10. LNP-mRNA Therapy Market Trends
Table 11. LNP-mRNA Therapy Market Drivers
Table 12. LNP-mRNA Therapy Market Challenges
Table 13. LNP-mRNA Therapy Market Restraints
Table 14. Global LNP-mRNA Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global LNP-mRNA Therapy Market Share by Players (2020-2025)
Table 16. Global Top LNP-mRNA Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LNP-mRNA Therapy as of 2024)
Table 17. Ranking of Global Top LNP-mRNA Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by LNP-mRNA Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of LNP-mRNA Therapy, Headquarters and Area Served
Table 20. Global Key Players of LNP-mRNA Therapy, Product and Application
Table 21. Global Key Players of LNP-mRNA Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global LNP-mRNA Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global LNP-mRNA Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global LNP-mRNA Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global LNP-mRNA Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global LNP-mRNA Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global LNP-mRNA Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global LNP-mRNA Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global LNP-mRNA Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America LNP-mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America LNP-mRNA Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America LNP-mRNA Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe LNP-mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe LNP-mRNA Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe LNP-mRNA Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific LNP-mRNA Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific LNP-mRNA Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific LNP-mRNA Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America LNP-mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America LNP-mRNA Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America LNP-mRNA Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa LNP-mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa LNP-mRNA Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa LNP-mRNA Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Genevant Sciences Company Details
Table 47. Genevant Sciences Business Overview
Table 48. Genevant Sciences LNP-mRNA Therapy Product
Table 49. Genevant Sciences Revenue in LNP-mRNA Therapy Business (2020-2025) & (US$ Million)
Table 50. Genevant Sciences Recent Development
Table 51. Moderna Company Details
Table 52. Moderna Business Overview
Table 53. Moderna LNP-mRNA Therapy Product
Table 54. Moderna Revenue in LNP-mRNA Therapy Business (2020-2025) & (US$ Million)
Table 55. Moderna Recent Development
Table 56. BioNTech Company Details
Table 57. BioNTech Business Overview
Table 58. BioNTech LNP-mRNA Therapy Product
Table 59. BioNTech Revenue in LNP-mRNA Therapy Business (2020-2025) & (US$ Million)
Table 60. BioNTech Recent Development
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer LNP-mRNA Therapy Product
Table 64. Pfizer Revenue in LNP-mRNA Therapy Business (2020-2025) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. NanoVation Therapeutics Company Details
Table 67. NanoVation Therapeutics Business Overview
Table 68. NanoVation Therapeutics LNP-mRNA Therapy Product
Table 69. NanoVation Therapeutics Revenue in LNP-mRNA Therapy Business (2020-2025) & (US$ Million)
Table 70. NanoVation Therapeutics Recent Development
Table 71. CureVac Company Details
Table 72. CureVac Business Overview
Table 73. CureVac LNP-mRNA Therapy Product
Table 74. CureVac Revenue in LNP-mRNA Therapy Business (2020-2025) & (US$ Million)
Table 75. CureVac Recent Development
Table 76. Sanofi Company Details
Table 77. Sanofi Business Overview
Table 78. Sanofi LNP-mRNA Therapy Product
Table 79. Sanofi Revenue in LNP-mRNA Therapy Business (2020-2025) & (US$ Million)
Table 80. Sanofi Recent Development
Table 81. Promab Company Details
Table 82. Promab Business Overview
Table 83. Promab LNP-mRNA Therapy Product
Table 84. Promab Revenue in LNP-mRNA Therapy Business (2020-2025) & (US$ Million)
Table 85. Promab Recent Development
Table 86. Grand Pharm Company Details
Table 87. Grand Pharm Business Overview
Table 88. Grand Pharm LNP-mRNA Therapy Product
Table 89. Grand Pharm Revenue in LNP-mRNA Therapy Business (2020-2025) & (US$ Million)
Table 90. Grand Pharm Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
Table 94. Authors List of This Report
List of Figures
Figure 1. LNP-mRNA Therapy Picture
Figure 2. Global LNP-mRNA Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global LNP-mRNA Therapy Market Share by Type: 2024 VS 2031
Figure 4. Passive Targeting Features
Figure 5. Active Targeting Features
Figure 6. Global LNP-mRNA Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global LNP-mRNA Therapy Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. LNP-mRNA Therapy Report Years Considered
Figure 12. Global LNP-mRNA Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global LNP-mRNA Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global LNP-mRNA Therapy Market Share by Region: 2024 VS 2031
Figure 15. Global LNP-mRNA Therapy Market Share by Players in 2024
Figure 16. Global LNP-mRNA Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by LNP-mRNA Therapy Revenue in 2024
Figure 18. North America LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America LNP-mRNA Therapy Market Share by Country (2020-2031)
Figure 20. United States LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe LNP-mRNA Therapy Market Share by Country (2020-2031)
Figure 24. Germany LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific LNP-mRNA Therapy Market Share by Region (2020-2031)
Figure 32. China LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America LNP-mRNA Therapy Market Share by Country (2020-2031)
Figure 40. Mexico LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa LNP-mRNA Therapy Market Share by Country (2020-2031)
Figure 44. Turkey LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Genevant Sciences Revenue Growth Rate in LNP-mRNA Therapy Business (2020-2025)
Figure 48. Moderna Revenue Growth Rate in LNP-mRNA Therapy Business (2020-2025)
Figure 49. BioNTech Revenue Growth Rate in LNP-mRNA Therapy Business (2020-2025)
Figure 50. Pfizer Revenue Growth Rate in LNP-mRNA Therapy Business (2020-2025)
Figure 51. NanoVation Therapeutics Revenue Growth Rate in LNP-mRNA Therapy Business (2020-2025)
Figure 52. CureVac Revenue Growth Rate in LNP-mRNA Therapy Business (2020-2025)
Figure 53. Sanofi Revenue Growth Rate in LNP-mRNA Therapy Business (2020-2025)
Figure 54. Promab Revenue Growth Rate in LNP-mRNA Therapy Business (2020-2025)
Figure 55. Grand Pharm Revenue Growth Rate in LNP-mRNA Therapy Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232